CorMedix Inc. (CRMD) vs 908 Devices Inc. (MASS)
A side-by-side comparison of CorMedix Inc. and 908 Devices Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRMD
CorMedix Inc.
$7.16HealthcareDelayed quote: Oct 6, 2026, 10:24 AM EDT
MASS
908 Devices Inc.
$12.51HealthcareDelayed quote: Oct 6, 2026, 10:25 AM EDT
Total return — CRMD vs MASS
growth of $100 · dividends reinvested · last 6yCRMD -9.0% (-1.6%/yr)MASS -73.9% (-20.0%/yr)CRMD compounded faster over this window
CRMD MASS
CRMD vs MASS: by the numbers
- •CRMD is the larger company ($562M vs $513M market cap).
- •CRMD is profitable (40.49% net margin) while MASS runs a net loss (-56.68%).
- •CRMD grew revenue faster over the past five years (352.03% vs 18.92% CAGR).
Metrics side by side
Valuation
| Metric | CRMD | MASS |
|---|---|---|
| P/E ratio | 3.36 | N/A |
| Forward P/E | 14.47 | N/A |
| P/S ratio | 1.22 | 8.44 |
| P/B ratio | 1.22 | 4.05 |
| EV / EBITDA | 1.79 | N/A |
| FCF yield | 44.53% | 0.09% |
Profitability
| Metric | CRMD | MASS |
|---|---|---|
| Gross margin | 82.78% | 49.79% |
| Operating margin | 46.95% | -46.01% |
| Net margin | 40.49% | -56.68% |
| ROE | 40.62% | -27.20% |
| ROIC | 27.87% | -18.90% |
Growth (annualized)
| Metric | CRMD | MASS |
|---|---|---|
| Revenue CAGR (5Y) | 352.03% | 18.92% |
| Total return CAGR (5Y) | 9.70% | -17.66% |
Frequently asked
- Which has grown faster, CRMD or MASS?
- Over the past five years, CRMD grew revenue faster — CRMD at a 352.03% CAGR versus MASS at 18.92%.
- Is CRMD or MASS more profitable?
- CRMD runs the higher net margin — CRMD at 40.49% versus MASS at -56.68%.
- How have CRMD and MASS total returns compared?
- Over the past 5 years, CRMD delivered 9.70% and MASS delivered -17.66% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CorMedix P/E ratioCorMedix ROE908 Devices ROECorMedix operating margin908 Devices operating marginCorMedix revenue growth908 Devices revenue growthCorMedix free cash flow908 Devices free cash flow
CorMedix & 908 Devices appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.